Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Fehrenbacher

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancerRoy S Herbst, Vincent J O'Neill, Louis Fehrenbacher, et al.
Breast Cancer Research : BCR|March 19, 2013
HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive diseaseLaurel A Habel, Lori C Sakoda, Ninah Achacoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01Hiroko Kunitake, Ping Zheng, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsDawn L Hershman, Lawrence H Kushi, Theresa Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
Breast Cancer Research and Treatment|September 17, 2011
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancerJennifer C Livaudais, Dawn L Hershman, Laurel Habel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic DiseaseMelody A Cobleigh, Charles L Vogel, Debu Tripathy, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working GroupStuart M Lichtman, R Donald Harvey, Marie-Anne Damiette Smit, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancerRoy S Herbst, Vincent J O'Neill, Louis Fehrenbacher, et al.
Breast Cancer Research : BCR|March 19, 2013
HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive diseaseLaurel A Habel, Lori C Sakoda, Ninah Achacoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01Hiroko Kunitake, Ping Zheng, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsDawn L Hershman, Lawrence H Kushi, Theresa Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
Breast Cancer Research and Treatment|September 17, 2011
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancerJennifer C Livaudais, Dawn L Hershman, Laurel Habel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic DiseaseMelody A Cobleigh, Charles L Vogel, Debu Tripathy, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2016
Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01Hiroko Kunitake, Marcia M Russell, Ping Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working GroupStuart M Lichtman, R Donald Harvey, Marie-Anne Damiette Smit, et al.
Pageof 9